rs9594293
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_207361.6(FREM2):c.6019+11650G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.212 in 152,032 control chromosomes in the GnomAD database, including 3,670 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_207361.6 intron
Scores
Clinical Significance
Conservation
Publications
- Fraser syndrome 2Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, G2P
- Fraser syndrome 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- renal agenesis, unilateralInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fraser syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_207361.6. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.212 AC: 32139AN: 151914Hom.: 3668 Cov.: 31 show subpopulations
GnomAD4 genome AF: 0.212 AC: 32166AN: 152032Hom.: 3670 Cov.: 31 AF XY: 0.209 AC XY: 15561AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at